Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis

NCT04668066 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis

NCT06248814 ·Status: COMPLETED ·Phase: PHASE1

Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma

NCT04927195 ·Status: COMPLETED ·Phase: PHASE1

Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis

NCT06487000 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT07220577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

NCT07216027 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis

NCT03235024 ·Status: COMPLETED ·Phase: PHASE2

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

NCT02780167 ·Status: COMPLETED ·Phase: PHASE2

Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis

NCT03568162 ·Status: COMPLETED ·Phase: PHASE2

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

NCT07011706 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis

NCT04212169 ·Status: COMPLETED ·Phase: PHASE2

Effect of Oral Steroids on Skin Outcomes in Atopic Dermatitis

NCT02908698 ·Status: TERMINATED ·Phase: NA

Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis

NCT03091426 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Trial of HY209gel in Atopic Dermatitis Patients

NCT06024499 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis

NCT05121480 ·Status: COMPLETED ·Phase: PHASE2

An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema

NCT03160248 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis

NCT02087943 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis

NCT05579899 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study of E6005 in Patients With Atopic Dermatitis

NCT01461941 ·Status: COMPLETED ·Phase: PHASE2

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

NCT07298395 ·Status: RECRUITING ·Phase: PHASE2

Safety and Efficacy of DNK333 in Atopic Dermatitis Patients

NCT01033097 ·Status: COMPLETED ·Phase: PHASE2

An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis

NCT00455429 ·Status: TERMINATED ·Phase: PHASE2

Clinical Study to Assess the Efficacy and Safety of DF277 Compared to Placebo in the Treatment of Otic Eczema

NCT01996748 ·Status: COMPLETED ·Phase: PHASE3

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

NCT03627767 ·Status: COMPLETED ·Phase: PHASE3

A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis

NCT03775434 ·Status: COMPLETED ·Phase: PHASE1